Cibus, Inc.
General ticker "CBUS" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.1B (TTM average)
Cibus, Inc. does not follow the US Stock Market performance with the rate: -1.7%.
Estimated limits based on current volatility of 4.6%: low 1.55$, high 1.70$
Factors to consider:
- Total employees count: 118 (-24.8%) as of 2025
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Going concern doubt, Need additional capital, Market competition, Technology obsolescence, Labor/talent shortage/retention
- Price in estimated range
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.97$, 2.80$]
- 2026-12-31 to 2027-12-31 estimated range: [0.99$, 2.78$]
Financial Metrics affecting the CBUS estimates:
- Positive: with PPE of -0.6 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: negative Operating cash flow
- Negative: negative Net income
- Positive: -1.23 < Investing cash flow per share per price, % of -0.74
- Positive: 7.04 < Shareholder equity ratio, % of 7.16 <= 12.78
Short-term CBUS quotes
Long-term CBUS plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $1.82MM | $4.26MM | $3.64MM |
| Operating Expenses | $320.70MM | $262.66MM | $101.17MM |
| Operating Income | $-318.88MM | $-258.40MM | $-97.53MM |
| Non-Operating Income | $-18.76MM | $-24.29MM | $-34.64MM |
| Interest Expense | $18.89MM | $34.19MM | $35.48MM |
| R&D Expense | $42.37MM | $50.43MM | $44.20MM |
| Income(Loss) | $-337.64MM | $-282.68MM | $-132.17MM |
| Taxes | $-0.00MM | $0.03MM | $0.03MM |
| Net Income(Loss)* | $-267.63MM | $-251.39MM | $-127.08MM |
| Stockholders Equity | $293.47MM | $92.16MM | $21.83MM |
| Assets | $544.41MM | $350.07MM | $305.05MM |
| Operating Cash Flow | $-46.21MM | $-58.04MM | $-50.59MM |
| Capital expenditure | $4.32MM | $0.81MM | $0.58MM |
| Investing Cash Flow | $55.06MM | $-0.81MM | $-0.58MM |
| Financing Cash Flow | $20.32MM | $40.60MM | $46.65MM |
| Earnings Per Share** | $-25.95 | $-10.83 | $-2.78 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.